Role of the sialophorin (CD43) receptor in mediating influenza A virus-induced polymorphonuclear leukocyte dysfunction.

Abstract:

:Polymorphonuclear leukocytes (PMNLs) exposed to influenza A virus (IAV) undergo activation of the respiratory burst followed by depression of cell function when subsequently exposed to particulate or soluble stimuli. The effect of IAV on PMNLs is likely to be mediated through the attachment of IAV to one or more specific receptors. Recently, IAV has been shown to bind to the sialophorin protein (CD43) receptor on PMNL plasma membranes. The present study was performed to determine if the sialophorin receptor was responsible for IAV-induced PMNL dysfunction. When PMNLs were incubated with IAV or CD43 monoclonal antibody (MoAb) for 30 minutes and then exposed to a secondary particulate (opsonized zymosan) or soluble (FMLP or phorbol 12-myristate 13-acetate) stimulus, there was significant depression of the PMNL chemiluminescence response compared with the equivalent control (P < .05). When PMNL were incubated with the CD43 MoAb and then cross-linked with a goat antimouse IgG antibody, no depression of PMNL function occurred upon secondary stimulation. Exposure of cells to IAV aggregates also eliminated the PMNL dysfunction that normally occurs due to the virus. Similar to IAV, PMNL dysfunction due to the CD43 MoAb could be overcome by priming the cells with granulocyte-macrophage colony-stimulating factor. These findings indicate that IAV-induced PMNL dysfunction is mediated, at least in part, through the sialophorin receptor.

journal_name

Blood

journal_title

Blood

authors

Abramson JS,Hudnor HR

subject

Has Abstract

pub_date

1995-03-15 00:00:00

pages

1615-9

issue

6

eissn

0006-4971

issn

1528-0020

journal_volume

85

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Reversing anti-factor Xa agents and the unmet needs in trauma patients.

    abstract::Andexanet alfa, a reversing agent for anticoagulants that inhibit factor Xa, has recently been licensed in the United States. We discuss the impact of this licensure on current practice and review in detail the problems of a neglected and growing clinical area: reversing the anticoagulation effect of factor Xa inhibit...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-850396

    authors: Hunt BJ,Neal MD,Stensballe J

    更新日期:2018-12-06 00:00:00

  • Inhibition of angiotensin I-converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells.

    abstract::Angiotensin I-converting enzyme (ACE) inhibitors can affect hematopoiesis by several mechanisms including inhibition of angiotensin II formation and increasing plasma concentrations of AcSDKP (acetyl-N-Ser-Asp-Lys-Pro), an ACE substrate and a negative regulator of hematopoiesis. We tested whether ACE inhibition could ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-11-3828

    authors: Charrier S,Michaud A,Badaoui S,Giroux S,Ezan E,Sainteny F,Corvol P,Vainchenker W

    更新日期:2004-08-15 00:00:00

  • Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a typically aggressive myeloid neoplasm of childhood that is clinically characterized by overproduction of monocytic cells that can infiltrate organs, including the spleen, liver, gastrointestinal tract, and lung. JMML is categorized as an overlap myelodysplastic syndrome/mye...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-03-300319

    authors: Chang TY,Dvorak CC,Loh ML

    更新日期:2014-10-16 00:00:00

  • Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation.

    abstract::Complement plays a key role in host defense, but its dysregulation can cause autologous tissue injury. Complement activation is normally controlled by regulatory proteins, including factor H (FH) in plasma and membrane cofactor protein (MCP) on the cell surface. Mutations in FH and MCP are linked to atypical hemolytic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-07-728253

    authors: Ueda Y,Mohammed I,Song D,Gullipalli D,Zhou L,Sato S,Wang Y,Gupta S,Cheng Z,Wang H,Bao J,Mao Y,Brass L,Zheng XL,Miwa T,Palmer M,Dunaief J,Song WC

    更新日期:2017-03-02 00:00:00

  • Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability.

    abstract::Interleukin-8 (IL-8) belongs to a family of chemoattractant cytokines involved in chemotaxis and activation of neutrophils. As in vivo administration of IL-8 induces granulocytosis and the release of immature white blood cells into the circulation, we assessed a possible mobilizing effect of IL-8 on myeloid progenitor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Laterveer L,Lindley IJ,Hamilton MS,Willemze R,Fibbe WE

    更新日期:1995-04-15 00:00:00

  • Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6.

    abstract::NF-IL6 was originally identified as a DNA binding protein regulating interleukin-1 (IL-1)-stimulated IL-6 expression. Direct cloning of NF-IL6 showed its homology with C/EBP, a hepatocyte- and adipocyte-specific transcription factor. This study showed that the expression of NF-IL6 messenger RNA (mRNA) increased marked...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Natsuka S,Akira S,Nishio Y,Hashimoto S,Sugita T,Isshiki H,Kishimoto T

    更新日期:1992-01-15 00:00:00

  • The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.

    abstract::Recently, we have demonstrated that human platelets carry preformed CD40 ligand (CD154) molecules, which rapidly appear on the platelet surface following stimulation by thrombin. Once on the surface, platelet CD154 induces an inflammatory reaction of CD40-bearing endothelial cells. This study shows that strong platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.4.1047

    authors: Henn V,Steinbach S,Büchner K,Presek P,Kroczek RA

    更新日期:2001-08-15 00:00:00

  • X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis.

    abstract::The JAK2V617F mutation is present in most patients with polycythemia vera (PV) and in some patients with essential thrombocythemia (ET) and myeloid metaplasia/myelofibrosis (MMM). We sought to investigate the relationship between granulocyte clonality and JAK2V617F allelic ratio. A total of 168 of 190 female patients ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-3900

    authors: Levine RL,Belisle C,Wadleigh M,Zahrieh D,Lee S,Chagnon P,Gilliland DG,Busque L

    更新日期:2006-05-15 00:00:00

  • Congenital dyserythropoietic anemias.

    abstract::Congenital dyserythropoietic anemias (CDAs) are a heterogeneous group of inherited anemias that affect the normal differentiation-proliferation pathways of the erythroid lineage. They belong to the wide group of ineffective erythropoiesis conditions that mainly result in monolinear cytopenia. CDAs are classified into ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000948

    authors: Iolascon A,Andolfo I,Russo R

    更新日期:2020-09-10 00:00:00

  • ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.

    abstract::ETS2 and ERG are transcription factors, encoded on human chromosome 21 (Hsa21), that have been implicated in human cancer. People with Down syndrome (DS), who are trisomic for Hsa21, are predisposed to acute megakaryoblastic leukemia (AMKL). DS-AMKL blasts harbor a mutation in GATA1, which leads to loss of full-length...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-08-174813

    authors: Stankiewicz MJ,Crispino JD

    更新日期:2009-04-02 00:00:00

  • Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction.

    abstract::C-C chemokine receptor type 7 (CCR7) is a chemokine receptor playing a pivotal role in the induction of human natural killer (NK)-cell migration to lymph nodes. We show that "licensed" peripheral blood killer immunoglobulin-like receptor-positive (KIR(+)) NK-cell populations, as well as KIR(+) NK-cell clones, de novo ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-05-222265

    authors: Marcenaro E,Cantoni C,Pesce S,Prato C,Pende D,Agaugué S,Moretta L,Moretta A

    更新日期:2009-11-05 00:00:00

  • A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.

    abstract::Peripheral blood (PB) CD34+ cells from four commonly used mobilization protocols were studied to compare their phenotype and proliferative capacity with steady-state PB or bone marrow (BM) CD34+ cells. Mobilized PB CD34+ cells were collected during hematopoietic recovery after myelosuppressive chemotherapy with or wit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: To LB,Haylock DN,Dowse T,Simmons PJ,Trimboli S,Ashman LK,Juttner CA

    更新日期:1994-11-01 00:00:00

  • The shortest isoform of C/EBPβ, liver inhibitory protein (LIP), collaborates with Evi1 to induce AML in a mouse BMT model.

    abstract::Ecotropic viral integration site 1 (Evi1) is one of the master regulators in the development of acute myeloid leukemia (AML) and myelodysplastic syndrome. High expression of Evi1 is found in 10% of patients with AML and indicates a poor outcome. Several recent studies have indicated that Evi1 requires collaborative fa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-368654

    authors: Watanabe-Okochi N,Yoshimi A,Sato T,Ikeda T,Kumano K,Taoka K,Satoh Y,Shinohara A,Tsuruta T,Masuda A,Yokota H,Yatomi Y,Takahashi K,Kitaura J,Kitamura T,Kurokawa M

    更新日期:2013-05-16 00:00:00

  • Identification of normal human peripheral blood monocytes and liver as sites of synthesis of coagulation factor XIII a-chain.

    abstract::Factor XIII is the fibrin-stabilizing factor that covalently cross-links fibrin monomers to form a highly organized, stable fibrin clot. The plasma form of factor XIII is a heterodimer, a2b2, consisting of two a-chains and two b-chains; the intracellular form, such as in platelets and placenta, is a dimer, a2, consist...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Weisberg LJ,Shiu DT,Conkling PR,Shuman MA

    更新日期:1987-08-01 00:00:00

  • Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy.

    abstract::Radioimmunotherapy (RIT) has emerged as an effective treatment for lymphoma, however the underlying mechanisms are poorly understood. We therefore investigated the relative contributions of antibody and targeted radiation to the clearance of tumor in vivo, using 2 different syngeneic murine B-cell lymphoma models. Alt...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-06-2037

    authors: Du Y,Honeychurch J,Cragg MS,Bayne M,Glennie MJ,Johnson PW,Illidge TM

    更新日期:2004-02-15 00:00:00

  • Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.

    abstract::Patients with classic hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) typically have high levels of Epstein-Barr virus (EBV) DNA in T cells and/or natural killer (NK) cells in blood and skin lesions induced by sun exposure that are infiltrated with EBV-infected lymphocytes. HVLPD is very rare in the Unit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2018893750

    authors: Cohen JI,Manoli I,Dowdell K,Krogmann TA,Tamura D,Radecki P,Bu W,Turk SP,Liepshutz K,Hornung RL,Fassihi H,Sarkany RP,Bonnycastle LL,Chines PS,Swift AJ,Myers TG,Levoska MA,DiGiovanna JJ,Collins FS,Kraemer KH,Pittalu

    更新日期:2019-06-27 00:00:00

  • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo.

    abstract::Defective function of dendritic cells (DC) in cancer has been recently described and may represent one of the mechanisms of tumor evasion from immune system control. We have previously shown in vitro that vascular endothelial growth factor (VEGF), produced by almost all tumors, is one of the tumor-derived factors resp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gabrilovich D,Ishida T,Oyama T,Ran S,Kravtsov V,Nadaf S,Carbone DP

    更新日期:1998-12-01 00:00:00

  • Clonal genetic and hematopoietic heterogeneity among human-induced pluripotent stem cell lines.

    abstract::Induced pluripotent stem cells (iPSCs) hold great promise for modeling human hematopoietic diseases. However, intrinsic variability in the capacities of different iPSC lines for hematopoietic development complicates comparative studies and is currently unexplained. We created and analyzed 3 separate iPSC clones from f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-484444

    authors: Mills JA,Wang K,Paluru P,Ying L,Lu L,Galvão AM,Xu D,Yao Y,Sullivan SK,Sullivan LM,Mac H,Omari A,Jean JC,Shen S,Gower A,Spira A,Mostoslavsky G,Kotton DN,French DL,Weiss MJ,Gadue P

    更新日期:2013-09-19 00:00:00

  • How I treat hepatitis C virus infection in patients with hematologic malignancies.

    abstract::Hepatitis C virus (HCV) infection is not uncommon in cancer patients. Over the past 5 years, treatment of chronic HCV infection in patients with hematologic malignancies has evolved rapidly as safe and effective direct-acting antivirals (DAAs) have become the standard-of-care treatment. Today, chronic HCV infection sh...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-05-718643

    authors: Torres HA,McDonald GB

    更新日期:2016-09-15 00:00:00

  • Interleukin 7 worsens graft-versus-host disease.

    abstract::Impaired immune reconstitution has moved to the forefront of clinical problems limiting progress in allogeneic bone marrow transplantation (BMT). The identification of therapies that can enhance immune reconstitution by increasing thymopoiesis is critical to solving this problem. Interleukin 7 (IL-7) is the most poten...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-04-1082

    authors: Sinha ML,Fry TJ,Fowler DH,Miller G,Mackall CL

    更新日期:2002-10-01 00:00:00

  • Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

    abstract::The stage of progenitor maturation and factors that determine the fate and clonal acquisition of human natural killer (NK) cell receptors during development are unknown. To study human NK cell receptor ontogeny, umbilical cord blood CD34(+)/Lin(-)/CD38(-) cells were cultured with a murine fetal liver line (AFT024) and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.3.705

    authors: Miller JS,McCullar V

    更新日期:2001-08-01 00:00:00

  • The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10.

    abstract::The inv(11)(p15q22) is a recurrent chromosomal abnormality associated with de novo and therapy-related myeloid malignancies. Here we report the molecular definition of this chromosomal aberration in four patients. Positional cloning showed the consistent rearrangement of the DDX10 gene on chromosome 11q22, which encod...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Arai Y,Hosoda F,Kobayashi H,Arai K,Hayashi Y,Kamada N,Kaneko Y,Ohki M

    更新日期:1997-06-01 00:00:00

  • Chlorambucil therapy in hairy cell leukemia: effects on lipid composition and lymphocyte subpopulations.

    abstract::Two patients with progressive hairy cell leukemia following splenectomy were treated with low-dose daily chlorambucil. Both had an objective hematologic response as determined by a return to normal hematocrit and platelet count. This was also reflected in the mononuclear cell fraction by the normalization of cholester...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Krigel R,Liebes LF,Pelle E,Silber R

    更新日期:1982-07-01 00:00:00

  • Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load.

    abstract::The expansion of follicular lymphomas (FLs) resembles, both morphologically and functionally, normal germinal center B-cell growth. The tumor cells proliferate in networks of follicular dendritic cells and are believed to be capable of somatic hypermutation and isotype switching. To investigate the relation between so...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Aarts WM,Bende RJ,Steenbergen EJ,Kluin PM,Ooms EC,Pals ST,van Noesel CJ

    更新日期:2000-05-01 00:00:00

  • Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia.

    abstract::We administered gemtuzumab ozogamycin ("mylotarg"; 9 mg/m(2) day 1 or 5) and all-trans retinoic acid (ATRA) to 19 patients with untreated acute promyelocytic leukemia (APL). There were 3 patients who also received idarubicin because of a white blood cell (WBC) count of more than 30 000/microL. In complete remission (C...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2001-12-0174

    authors: Estey EH,Giles FJ,Beran M,O'Brien S,Pierce SA,Faderl SH,Cortes JE,Kantarjian HM

    更新日期:2002-06-01 00:00:00

  • Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene.

    abstract::An animal model for malignant mastocytosis is described in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. The lethal mast cell disease is characterized by massive infiltration of bone marrow, spleen, and several other visceral organs by connective tissue mast cells, which normally reside in ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: von Rüden T,Kandels S,Radaszkiewicz T,Ullrich A,Wagner EF

    更新日期:1992-06-15 00:00:00

  • Detection of soluble intermediates of the fibrinogen-fibrin conversion using erythrocytes coated with fibrin monomers.

    abstract::The presence of minimal amounts of fibrinogen-fibrin intermediates in human plasma was visualized by an agglutination reaction of glutaraldehyde-treated human erythrocytes coated with purified fibrin monomers. A degree of monomer coating was established which produced erythrocytes not agglutinated by normal plasma but...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Largo R,Heller V,Straub PW

    更新日期:1976-06-01 00:00:00

  • Thromboprophylaxis in cancer outpatients.

    abstract::In this issue of Blood, Khorana and colleagues report a simple and practical model for the prediction of symptomatic venous thrombosis after the initiation of chemotherapy in cancer outpatients. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2008-02-137760

    authors: Doggen CJ

    更新日期:2008-05-15 00:00:00

  • IL-15 produced and trans-presented by DCs underlies homeostatic competition between CD8 and {gamma}{delta} T cells in vivo.

    abstract::Homeostatic mechanism by which peripheral T-cell subsets are maintained in vivo remains largely unknown. Using a T-cell proliferation model under lymphopenic settings, we now demonstrate that gammadelta T cells limit CD8 T-cell expansion but not the initial proliferation after transfer into lymphopenic recipients. Int...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-192997

    authors: Do JS,Min B

    更新日期:2009-06-18 00:00:00

  • Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.

    abstract::Atypical hemolytic-uremic syndrome (aHUS) is associated with genetic complement abnormalities/anti-complement factor H antibodies, which paved the way to treatment with eculizumab. We studied 44 aHUS patients and their relatives to (1) test new assays of complement activation, (2) verify whether such abnormality occur...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2014-02-558296

    authors: Noris M,Galbusera M,Gastoldi S,Macor P,Banterla F,Bresin E,Tripodo C,Bettoni S,Donadelli R,Valoti E,Tedesco F,Amore A,Coppo R,Ruggenenti P,Gotti E,Remuzzi G

    更新日期:2014-09-11 00:00:00